<?xml version="1.0" encoding="UTF-8"?>
<p>Due to its persistence in the blood, Zika IgG is particularly useful for mapping patterns of infection and predicting future outbreaks and is used by the WHO in reporting and confirming outbreaks [
 <xref rid="B13-tropicalmed-05-00097" ref-type="bibr">13</xref>]. Zika IgG has also been found to be present in high levels in infants born with microcephaly, suggesting it might also be important in assessing maternal–fetal disease transmission [
 <xref rid="B27-tropicalmed-05-00097" ref-type="bibr">27</xref>]. This study demonstrates that the Elecsys
 <sup>®</sup> Zika IgG assay is highly specific and is a promising tool for use in monitoring Zika seroprevalence and infection.
</p>
